metformin has been researched along with Asthenia in 1 studies
Metformin: A biguanide hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. Metformin improves glycemic control by improving insulin sensitivity and decreasing intestinal absorption of glucose. (From Martindale, The Extra Pharmacopoeia, 30th ed, p289)
metformin : A member of the class of guanidines that is biguanide the carrying two methyl substituents at position 1.
Asthenia: Clinical sign or symptom manifested as debility, or lack or loss of strength and energy.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Duwoos, H | 1 |
| Bertrand, CM | 1 |
| Husson, A | 1 |
| Cramer, J | 1 |
| Tayot, J | 1 |
1 other study available for metformin and Asthenia
| Article | Year |
|---|---|
[Reversible hyperlactatemia induced by phenformin with muscular asthenia and cardio-respiratory signs].
Topics: Aged; Animals; Asthenia; Diabetes Complications; Diabetic Ketoacidosis; Dyspnea; Heart Diseases; Hep | 1970 |